We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03671148
Brief Title: A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis Including Those Who Have a History of Inadequate Response or Intolerance to Biologic Therapy(Ies) (KEEPsAKE2)

First Submitted : September 12, 2018
First Submitted that Met QC Criteria : September 12, 2018
First Posted : September 14, 2018

Results First Submitted : February 1, 2022
Results First Posted with QC Comments : February 25, 2022
Results First Submitted that Met QC Criteria : February 28, 2022
Results First Posted : March 2, 2022

Certification/Extension First Submitted : June 7, 2021
Certification/Extension First Submitted that Met QC Criteria : February 28, 2022
Certification/Extension First Posted : March 2, 2022

Last Update Submitted that Met QC Criteria : February 28, 2022
Last Update Posted : March 2, 2022